Accelerating Scientific Discovery with Autonomous Goal-evolving Agents
TLDR
Introduces SAGA, a bi-level LLM agent that automates objective function design to accelerate scientific discovery, validated on multiple real-world tasks.
Reasoning
The paper presents a novel bi-level architecture for autonomous scientific discovery, with strong empirical validation across diverse domains including antibiotics and nanobodies. However, the abstract lacks details on methodology limitations and comparison baselines.
Read-first score
Read-first score 55.5, weighted from topical fit, citation, graph, method, reproducibility, and recency signals. Original total remains 67.
Field roles
Rank sensitivity
Stability: volatile; rank range: 55.
Keyword Scores
Deep Analysis
Innovations
- Automating objective function design for scientific discovery agents, addressing a central unmet need
- Bi-level architecture with outer LLM agents that propose and convert objectives into scoring functions, and inner optimization loop
- Systematic exploration of the space of objectives and their trade-offs instead of fixed inputs
Methodology
SAGA employs a bi-level architecture: an outer loop of LLM agents analyzes optimization outcomes, proposes new objectives, and converts them into computable scoring functions, while an inner loop performs solution optimization under the current objectives. The framework is demonstrated across antibiotics, nanobodies, functional DNA sequences, inorganic materials, and chemical processes.
Key Results
Experimental validation identified a structurally novel antibiotic hit with promising potency and safety for E. coli, and three de novo PD-L1 binders in nanobody design.